• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管疾病人群筛查对生活质量的影响。

The impact of population screening for cardiovascular disease on quality of life.

作者信息

Søgaard Rikke, Diederichsen Axel, Lindholt Jes

机构信息

Institute of Clinical Research, University of Southern Denmark, J.B. Winsløws Vej 4, Odense 5000, Denmark.

Department of Cardiology, Odense University Hospital, Odense, Denmark.

出版信息

Eur Heart J Open. 2023 May 23;3(3):oead055. doi: 10.1093/ehjopen/oead055. eCollection 2023 May.

DOI:10.1093/ehjopen/oead055
PMID:37293138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10246813/
Abstract

AIMS

To examine the impact of population screening-generated events on quality of life: invitation, positive test result, initiation of preventive medication, enrolment in follow-up at the surgical department, and preventive surgical repair.

METHODS AND RESULTS

A difference-in-difference design based on data collected alongside two randomized controlled trials where general population men were randomized to screening for cardiovascular disease or to no screening. Repeated measurements of health-related quality of life (HRQoL) were conducted up to 3 years after inclusion using all relevant scales of the EuroQol instrument: the anxiety/depression dimension, the EuroQol 5-dimension profile index (using Danish preference weights), and the visual analogue scale for global health. We compare the mean change scores from before to after events for groups experiencing vs. not experiencing the events. Propensity score matching is additionally used to provide both unmatched and matched results. Invitees reported to be marginally better off than non-invitees on all scales of the EuroQol. For events of receiving the test result, initiating preventive medication, being enrolled in surveillance, and undergoing surgical repair, we observed no impact on overall HRQoL but a minor impact of being enrolled in surveillance on emotional distress, which did not persist after matching.

CONCLUSION

The often-claimed detrimental consequences of screening to HRQoL could not be generally confirmed. Amongst the screening events assessed, only two possible consequences were revealed: a reassurance effect after a negative screening test and a minor negative impact to emotional distress of being enrolled in surveillance that did not spill over to overall HRQoL.

摘要

目的

研究人群筛查所产生的事件对生活质量的影响,这些事件包括:收到筛查邀请、检测结果呈阳性、开始预防性药物治疗、在外科部门登记接受随访以及进行预防性手术修复。

方法与结果

采用差异中的差异设计,该设计基于在两项随机对照试验过程中收集的数据,在这两项试验中,将普通男性人群随机分为接受心血管疾病筛查组或不接受筛查组。使用欧洲生活质量量表(EuroQol)的所有相关量表,在纳入研究后长达3年的时间里对健康相关生活质量(HRQoL)进行重复测量:焦虑/抑郁维度、欧洲生活质量五维度概况指数(使用丹麦偏好权重)以及整体健康视觉模拟量表。我们比较了经历这些事件与未经历这些事件的组在事件前后的平均变化得分。此外,使用倾向得分匹配法来提供未匹配和匹配后的结果。在欧洲生活质量量表的所有维度上,收到邀请者的状况略好于未收到邀请者。对于收到检测结果、开始预防性药物治疗、登记接受监测以及接受手术修复这些事件,我们观察到对整体健康相关生活质量没有影响,但登记接受监测对情绪困扰有轻微影响,在匹配后这种影响不再持续。

结论

通常所说的筛查对健康相关生活质量产生有害影响这一说法无法得到普遍证实。在评估的筛查事件中,仅发现了两种可能的后果:阴性筛查试验后的安心效应以及登记接受监测对情绪困扰产生的轻微负面影响,且这种影响并未波及整体健康相关生活质量。

相似文献

1
The impact of population screening for cardiovascular disease on quality of life.心血管疾病人群筛查对生活质量的影响。
Eur Heart J Open. 2023 May 23;3(3):oead055. doi: 10.1093/ehjopen/oead055. eCollection 2023 May.
2
Assessment of Health-Related Quality of Life Using EuroQoL-5 Dimension in Populations With Prediabetes, Diabetes, and Normal Glycemic Levels in Southwest China.在中国西南部,使用欧洲五维健康量表评估处于糖尿病前期、糖尿病和正常血糖水平的人群的健康相关生活质量。
Front Public Health. 2021 Oct 12;9:690111. doi: 10.3389/fpubh.2021.690111. eCollection 2021.
3
The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes.非酒精性脂肪性肝炎的负担:对健康相关生活质量和患者报告结局的系统评价。
JHEP Rep. 2022 Jun 15;4(9):100525. doi: 10.1016/j.jhepr.2022.100525. eCollection 2022 Sep.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
EuroQOL-5D-3L does not adequately map quality-of-life deterioration in severely affected patients with epilepsy.EuroQOL-5D-3L 在严重癫痫患者中不能充分映射生活质量的恶化。
Epilepsy Behav. 2022 Feb;127:108554. doi: 10.1016/j.yebeh.2022.108554. Epub 2022 Jan 18.
6
7
Health-related quality of life among Indian population: The EQ-5D population norms for India.印度人群的健康相关生活质量:印度 EQ-5D 人群正常值。
J Glob Health. 2023 Feb 17;13:04018. doi: 10.7189/jogh.13.04018.
8
Changes in health-related quality of life before and after a 12-month enhanced primary care model among chronically ill primary care patients in Australia.澳大利亚慢性病初级保健患者接受强化初级保健模式前后健康相关生活质量的变化。
Health Qual Life Outcomes. 2020 Aug 24;18(1):288. doi: 10.1186/s12955-020-01539-1.
9
Health-related quality of life in HIV/AIDS patients on antiretroviral therapy at a tertiary care facility in Zimbabwe.津巴布韦一家三级医疗机构中接受抗逆转录病毒治疗的艾滋病毒/艾滋病患者的健康相关生活质量。
AIDS Care. 2016 Jul;28(7):904-12. doi: 10.1080/09540121.2016.1173639. Epub 2016 Apr 21.
10
Health-related quality of life during three trimesters of pregnancy in Morocco: cross-sectional pilot study.摩洛哥孕期三个阶段的健康相关生活质量:横断面试点研究。
EClinicalMedicine. 2023 Feb 4;57:101837. doi: 10.1016/j.eclinm.2023.101837. eCollection 2023 Mar.

引用本文的文献

1
Short-term impact of cardiovascular screening by traditional risk assessment or coronary artery calcium score on health-related quality of life: the ROBINSCA trial.传统风险评估或冠状动脉钙化评分进行心血管筛查对健康相关生活质量的短期影响:ROBINSCA试验
Eur Heart J Open. 2024 Sep 23;4(5):oeae080. doi: 10.1093/ehjopen/oeae080. eCollection 2024 Sep.
2
Barriers and facilitators to mental health promotion for Mexican immigrants in the U.S. through the Ventanillas de Salud program.通过“健康之窗”项目促进美国墨西哥移民心理健康的障碍和促进因素。
Front Public Health. 2023 Sep 28;11:1268253. doi: 10.3389/fpubh.2023.1268253. eCollection 2023.

本文引用的文献

1
Cost effectiveness of population screening vs. no screening for cardiovascular disease: the Danish Cardiovascular Screening trial (DANCAVAS).人群心血管疾病筛查与不筛查的成本效益比较:丹麦心血管疾病筛查试验(DANCAVAS)。
Eur Heart J. 2022 Nov 1;43(41):4392-4402. doi: 10.1093/eurheartj/ehac488.
2
Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial.丹麦心血管疾病筛查(DANCAVAS)试验的五年结果。
N Engl J Med. 2022 Oct 13;387(15):1385-1394. doi: 10.1056/NEJMoa2208681. Epub 2022 Aug 27.
3
Interventions in hypertension: systematic review and meta-analysis of natural and quasi-experiments.高血压干预措施:自然实验和准实验的系统评价与荟萃分析
Clin Hypertens. 2022 May 1;28(1):13. doi: 10.1186/s40885-022-00198-2.
4
Why and when to screen for cardiovascular disease in healthy individuals.为何以及何时对健康个体进行心血管疾病筛查。
Heart. 2021 May 26;107(12):1010-1017. doi: 10.1136/heartjnl-2019-316266.
5
Systematic Review and Meta-Analysis of Health Related Quality of Life and Reported Experiences in Patients With Abdominal Aortic Aneurysm Under Ultrasound Surveillance.超声监测下腹主动脉瘤患者健康相关生活质量和报告体验的系统评价和荟萃分析。
Eur J Vasc Endovasc Surg. 2020 Mar;59(3):420-427. doi: 10.1016/j.ejvs.2019.07.021. Epub 2020 Jan 10.
6
Screening for Abdominal Aortic Aneurysm: US Preventive Services Task Force Recommendation Statement.筛查腹主动脉瘤:美国预防服务工作组推荐声明。
JAMA. 2019 Dec 10;322(22):2211-2218. doi: 10.1001/jama.2019.18928.
7
Baseline findings of the population-based, randomized, multifaceted Danish cardiovascular screening trial (DANCAVAS) of men aged 65-74 years.丹麦基于人群的、随机的、多方面的心血管筛查试验(DANCAVAS)的基线研究结果,该试验对象为 65-74 岁的男性。
Br J Surg. 2019 Jun;106(7):862-871. doi: 10.1002/bjs.11135. Epub 2019 Mar 27.
8
Impact of abdominal aortic aneurysm screening on quality of life.腹主动脉瘤筛查对生活质量的影响。
Br J Surg. 2018 Feb;105(3):203-208. doi: 10.1002/bjs.10721.
9
Quality of life assumptions determine which cervical cancer screening strategies are cost-effective.生活质量假设决定了哪些宫颈癌筛查策略具有成本效益。
Int J Cancer. 2018 Jun 1;142(11):2383-2393. doi: 10.1002/ijc.31265. Epub 2018 Feb 8.
10
Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial.丹麦男性血管疾病人群筛查与干预(VIVA):一项随机对照试验
Lancet. 2017 Nov 18;390(10109):2256-2265. doi: 10.1016/S0140-6736(17)32250-X. Epub 2017 Aug 28.